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Abstract
To study the effect of the splicing of HSV-1 latency-associated transcript (LAT) on viral latency, we constructed two mutant viruses
(FH and FH) in which the 168-bp HpaI–HpaI fragment within the 2-kb LAT intron was replaced by a 447-bp bacteriophage lambda
sequence. The lambda DNA was inserted in opposite orientations in FH and FH. The mutation in FH disrupted the splicing of
LAT primary transcript and altered both LAT exon and intron, whereas the mutation in FH virus preserved the wild-type splice sites and
the wild-type exon. Quantitative PCR analysis revealed that during latency there was a reduction in the number of viral genomes in mouse
trigeminal ganglia infected with FH but not in those infected with FH. The decrease in the latent genome numbers was not due to
a defect in viral replication during the acute stage of infection. Furthermore, trigeminal ganglia from mice latently infected with FH
displayed a slower reactivation kinetics compared to those infected with the parental strain. To elucidate the mechanism, we examined the
antiapoptotic properties of these LAT constructs. A plasmid containing the pH construct was found to be less protective for cells against
apoptosis than plasmid containing the wild-type or pH constuct. These results suggest that the splicing of LAT primary transcript, and
thus the correctly spliced exon product, play an important role in promoting the establishment and/or maintenance of viral latency.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Herpes simplex virus type 1 (HSV-1) establishes latent
infections in the sensory ganglia of the peripheral nervous
system (for review see Wagner and Bloom, 1997). During
latency, only a diploid gene within the long repeat region of
the viral genome is actively transcribed. Transcripts from
this gene are known as latency-associated transcripts
(LATs). LATs are present as several nonpolyadenylated
collinear RNAs, including a major 2-kb LAT intron and 1.4
kb-and 1.5-kb splice variants (Spivack, Woods, and Fraser,
1991; Wagner et al., 1988a). The 2-kb LAT is believed to be
a stable intron spliced from a low-abundance 8.3-kb primary
transcript (minor LAT or mLAT) (Dobson et al., 1989;
Farrell, Dobson, and Feldman, 1991; Mitchell, Lirette, and
Fraser, 1990). However, exons from this primary transcript
mLAT have been hard to detect. The 2-kb LAT is expressed
in productively infected cells and in latently infected neu-
rons. Interestingly it is found primarily in the nucleus of
latently infected neurons (Deatly et al., 1987; Stevens et al.,
1987), although it is also present in the cytoplasm of acutely
infected cells (Nicosia et al., 1994). The 1.4- and 1.5-kb
variants can only be detected during latency (Spivack and
Fraser, 1987; Wagner et al., 1988b).
The precise role of LATs in the HSV-1 life cycle has yet
to be determined. LATs have been determined to play a role
in reactivation from latency since some LAT mutant viruses
display slow or reduced reactivation phenotypes in a variety
of animal models (Block et al., 1992, 1996; Hill et al., 1990;
Leib et al., 1989; Perng et al., 1994; Trousdale et al., 1991).
Several lines of evidence also suggest that LAT is important
in promoting the establishment and maintenance of viral
latency (Perng et al., 2000b; Sawtell and Thompson, 1992;
Thompson and Sawtell, 1997). The mechanism by which
LATs may be functioning in these processes is still un-
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known. It has also been hypothesized that LATs may func-
tion to suppress viral gene expression during productive
infections (Garber, Schaffer, and Knipe, 1997; Mador et al.,
1998) and/or promote neuron survival though an antiapop-
totic mechanism (Inman et al., 2001; Perng et al., 2000a;
Thompson and Sawtell, 2001). Early studies on LAT func-
tion were mainly focused on the 2-kb LAT intron because of
its high abundance during latency and the presence of sev-
eral potential open reading frames within it (Spivack,
Woods, and Fraser, 1991; Wechsler et al., 1989). Much of
the evidence has come from studies involving the use of
LAT mutant viruses. Most of the LAT mutant viruses stud-
ied possess large deletions in the LAT region, affecting both
the 2-kb LAT intron and the putative exons of the LAT
primary transcript. Thus it is uncertain whether the pheno-
types observed in these LAT mutants are attributed to the
disruption of the 2-kb LAT intron or the putative exons.
Recent studies suggested it is the first 1.5 kb of the LAT
primary transcript, rather than the 2-kb LAT intron, that
promotes neuron survival and spontaneous virus reactiva-
tion (Inman et al., 2001; Thompson and Sawtell, 2001),
though there is some evidence of intron involvement
(Ahmed et al., 2002).
A previously described LAT mutant virus, TB1, contains
447 bp of bacteriophage lambda DNA in place of the 168 bp
of HpaI–HpaI fragment within the 2-kb LAT of HSV-1
strain HFEM (see Fig. 1) (Block et al., 1990). As shown in
a previous study, the lambda insert introduced a splice
donor and splice acceptor site into the 2-kb LAT intron,
resulting in the expression of a stable truncated 0.9-kb
intron in productively infected cells (Krummenacher, Zabo-
lotny, and Fraser, 1997). In cells productively infected with
TB1, a lambda-sequence-containing exon was observed
(Krummenacher, Zabolotny, and Fraser, 1997). The 0.9-kb
intron was spliced out using the splice donor in the lambda
insert and the wild-type 2-kb LAT splice acceptor and is
stable because it maintains the 2-kb LAT splice branch
point region (Zabolotny, Krummenacher, and Fraser, 1997).
However, the truncated LAT intron could not be detected in
vivo in latently infected mouse trigeminal ganglia. Thus it is
unclear why the modified stable LAT intron from TB1 is
detected in tissue culture infections but not in latently in-
fected tissue. Is it because the stability is different in PNS
tissue compared to cell culture or is it because the virus with
the altered intron forms, or maintains, latency with reduced
efficiency? In the previous study (Krummenacher, Zabo-
lotny, and Fraser, 1997), a LAT minigene expression plas-
mid (pH) was also constructed in which the same
lambda fragment was inserted in the opposite direction to
that in TB1. The cryptic splice donor site was eliminated in
the pH construct. Following transfection into cells, a
wild-type exon and a large stable intron were expressed
from this plasmid.
In the present study, we examined the effect of disrupting
mLAT splicing on viral latency. We constructed a TB1-like
mutant virus, FH, in HSV-1 strain F background. In this
way we overcame the potential problems of using mutant
TB1 that was made in viral strain HFEM, which has a large
deletion in one copy of the repeat long region of its genome.
The 447-bp lambda fragment was also inserted in the op-
posite orientation to that found in FH to generate virus
FH. These viruses were then examined for their abilities
to establish latent infections and reactivate from latency.
Results
Characterization of HSV-1 mutants FH and FH
To examine the role of the LAT primary transcript and
its spliced products in latency, we constructed mutant virus
FH and FH as described under Materials and Meth-
ods. In these mutant viruses the 168-bp HpaI–HpaI frag-
ment within the 2kb LAT intron was replaced by a 447-bp
bacteriophage lambda DNA (Fig. 1). The FH virus has
the same mutation in the LAT region as the previously
described LAT mutant virus TB1 ((Block et al., 1990),
except that it was constructed in the HSV-1 strain F back-
ground, whereas TB1 virus was derived from HSV-1 strain
HFEM. It has been shown previously that this replacement
mutation did not affect the expression of viral immediate-
early gene ICP0 in productively infected cells (Block et al.,
1990). The FH virus has the 447-bp lambda DNA in-
serted in the opposite orientation of that in FH. As
shown in Fig. 1, the lambda insertion introduced several
novel restriction enzyme sites (BamHI, BstEII, and PstI),
which are absent in HpaI–HpaI fragment of the wild-type
Fig. 1. Genomic structures of mutant viruses. (A) The HSV-1 genome. (B)
Detailed map of the UL/IRL region encoding the LATs. (C) Enlarged map
of PstI–MluI fragments of wild-type and mutant viruses. The 168-bp
HpaI–HpaI fragment (nts 5902–6070 and nts 120300–120468 of the
HSV-1 genome) within the 2-kb LAT intron was replaced by a 440-bp
HpaI–HpaI bacteriophage lambda sequence (nts 5269–5711 of lambda
genome). The lambda fragments were inserted in opposite orientations in
the FH and FH. Restriction enzyme sites are abbreviated as follows:
P, PstI; M, MluI; B, BstEII; H, HpaI. Locations of PF and PR2 primers are
labeled with arrows.
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HSV-1, allowing easy identification of the lambda se-
quence. To confirm the lambda insertion and assess HSV-1
genome integrity, viral DNA was prepared from infected
Vero cells, digested with restriction enzymes, and subjected
to Southern blot analysis (Fig. 2A–C). In BamHI digests, the
3 BstEII–BstEII LAT intron probe hybridized to a 9-kb and
an 11-kb band of parental strain F, corresponding to HSV-1
BamHI-E and BamHI-B fragments. This probe recognized
6- and 8-kb bands in digests of mutant viral DNA because
an extra BamHI site was introduced by the lambda insert. In
the SalI and EcoRV digests, the BstEII–BstEII probe hy-
bridized to two fragments with both wild-type and mutant
viruses. There were slight shifts of band sizes in the mutants
because their LAT containing fragments are 280 bp larger
than the wild-type ones. To confirm the orientation of the
lambda insert, the polymerase chain reaction (PCR) was
performed to amplify the first 1030 bp of the 2-kb LAT
intron. As shown in Fig. 2D, the size of PCR products from
mutant viral constructs was about 1300 bp, showing a
280-bp size increase from the wild-type. The PCR products
were purified and digested with BstEII and PstI (see Fig. 1C
for positions). As shown in Fig. 2E, the FH virus showed
the same pattern as the virus TB1 and a different pattern
from the virus FH.
The growth kinetics of recombinant viruses was assessed
on Vero cells. Cells were infected at a m.o.i. of 0.1 and
harvested at various time points postinfection as indicated.
Infected cells were harvested and sonicated briefly to re-
lease viral particles after three rounds of freezing thawing.
Virus titer was determined on Vero cells. There were no
differences in replication kinetics among wild-type, FH,
and FH on Vero cells (Fig. 3).
Replication of wild-type and mutant HSV-1 in mouse
trigeminal ganglia during acute infection
Numbers of HSV-1 genomes in infected mouse trigem-
inal ganglia were determined by quantitative PCR analysis
(as described under Materials and Methods). The PCR stan-
dard curve measured ratios ranging from 0.001 to 1000
HSV-1 genome copies per mouse cell. HSV-1 genome
numbers in trigeminal ganglion DNA samples were deter-
mined by measuring viral UL54 (ICP 27) or UL39 (ribo-
nucleotide reductase) genes through PCR amplification and
normalizing to the cellular gene cyclophilin.
The replication kinetics of HSV-1 DNA in mouse tri-
geminal ganglia acutely infected was examined. Mice were
infected by corneal scarification with either the parental
strain HSV-1 or the mutants. At various times postinfection,
mice were sacrificed. Trigeminal ganglia from three mice
were pooled as one group and ganglionic DNA was ex-
tracted. Ganglionic DNA samples were diluted to a final
concentration of 100 ng/l and subjected to quantitative
Fig. 2. Analysis of mutant virus constructs. (A–C) Southern blot analysis
of recombinant viral constructs. Viral DNA was digested with restriction
enzymes, separated by agarose gel electrophoresis, and transferred to
nitrocellulose membranes. Restriction enzymes used were BamHI (A), SalI
(B), and EcoRV (C). Panel A was hybridized with a BstEII–BstEII probe
that spans the 3 end of LAT exon 1 and 5 end of the LAT intron. Panels
B and C were hybridized with a BstEII–BstEII probe that covers only part
of the LAT intron. (Lane 1) HSV-1 F, (lane 2) HSV-1 FH, and (lane 3)
HSV-1 FH. (D and E) PCR analysis of recombinant viral constructs.
Ten nanograms of viral DNA were subjected to PCR analysis using
primers PF and PR2. The primer pair amplifies the first 1029 bp of the 2-kb
LAT intron. PCR products were separated by agarose gel electrophoresis
(D). The PCR products from the mutant viruses were 280 bp larger than
that from the wild-type because of the lambda insertions in the mutant
viruses. To verify the orientation of the mutant virus insertions, restriction
enzyme digestion on purified PCR products was performed (E: PstI, left;
BstEII, right). The lambda insert has a PstI site that is absent in the
wild-type virus. The lambda insert also adds an extra BstEII site in addition
to the one present in the wild-type. See Fig. 1 for positions. Lane labels are
1, TB1; 2, F; 3, FH; and 4, FH.
Fig. 3. Growth kinetics of wild-type and mutant viruses in Vero cells.
Subconfluent monolayers of Vero cells were inoculated with HSV-1 at a
m.o.i. of 0.1. At various times as indicated, infected monolayers were
harvested, frozen-thawed three times, and briefly sonicated. Progeny vi-
ruses were determined Vero cells. Each point represents the average of
three individual experiments.
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PCR analysis (as described under Materials and Methods).
The results are shown in Fig. 4 and represent the average of
at least three individual experiments. The peak for the
amount of HSV-1 DNA present in the trigeminal ganglia
was around days 3–4 postinfection. Interestingly FH-
infected mice appeared to have higher levels of viral DNA
during this peak time compared to those infected with the
parental strain F (Fig. 4A). However, the difference was not
statistically significant (P  0.09, paired t test). There was
a more rapid decline in viral genome numbers in FH-
infected animals at day 7 postinfection compared to that at
day 3. Interestingly, by day 10 postinfection, all mutant and
wild-type virus-infected mice contained similar numbers of
viral genomes in trigeminal ganglia.
The acute replication of virus TB1 showed a similar
profile to that of FH when it was compared to the
parental strain HFEM (Fig. 4B).
HSV-1 genome numbers in mouse trigeminal ganglia
latently infected with FH and TB1 are reduced
compared to the parental strains
To test the effect of disrupting the LAT region on estab-
lishment and maintenance of viral latency, we compared
number of HSV-1 genomes in the mouse trigeminal ganglia
latently infected with LAT mutant viruses to those infected
with parental strains. Mice were infected with parental
strain and mutant viruses by corneal scarification bilaterally
at 106 PFU per eye. Thirty days after infection, mice were
sacrificed. Ganglion DNA was extracted and subjected to
quantitative PCR analysis. The results are shown in Fig. 5
and represent the average of at least five individual exper-
iments. There was a significant reduction in HSV-1 DNA
levels in FH-infected mouse trigeminal ganglia (paired t
test, P  0.02) compared to those infected with parental
strain F. The average number of HSV-1 genome copies per
cell was about 0.02 in mice infected with FH virus and
was about 0.1 in mice infected with wild-type strain F (Fig.
5A). A similar reduction in HSV-1 genome numbers was
also observed in mice infected with TB1 compared to those
infected with parental strain HFEM (Fig. 5B). The reduction
in latent HSV-1 genome numbers was not due to a replica-
tion deficiency because the mutant replicated as efficiently
as the parental strain during acute infection (Fig. 4).
Fig. 4. Replication kinetics of viral DNA in mouse TG during acute
infection. The presence of HSV-1 viral DNA was quantified by PCR
analysis measuring viral gene UL54 and UL39 and then normalized by
cellular gene cyclophilin. (A and B) HSV-1 viral DNA replication during
acute infections in mouse trigeminal ganglia. Mice were infected by cor-
neal scarification and sacrificed at various time points as indicated. Three
pairs of TG were pooled as one group and ganglionic DNA was extracted.
Infected TG DNA samples were subjected to quantitative PCR analysis.
Values represent mean  SEM of at least three independent experiment
groups.
Fig. 5. Quantitation of latent viral genomes in mouse trigeminal ganglia.
Mice were infected with wild-type, mutant, and rescuant viruses by corneal
scarification and sacrificed 30 days postinfection. Three pairs of ganglia
were pooled as one group. Ganglionic DNA was extracted and subjected to
quantitative PCR analysis. Values represent mean  SEM of at least five
independent experimental groups.
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The FH rescuant virus, FHR, was also examined.
It was found that the level of HSV-1 DNA in mouse tri-
geminal ganglia latently infected with FHR was similar
to that of the wild-type strain F. FH and TB1 contain the
same replacement mutation in the LAT region but were
constructed in different HSV-1 parental strains. The reduc-
tion of HSV-1 DNA levels in FH and TB1-infected
mouse trigeminal ganglia during latency suggest that the
disruption of the LAT region in FH and TB1 viruses
affects the establishment or maintenance of latency, result-
ing in a diminished number of copies of latent viral DNA.
FH- and wild-type HSV-1 show similar number of HSV-1
genomes during latency in mouse trigeminal ganglia
Previous work suggested that inserting the 447-bp
lambda DNA into the 2-kb LAT intron in opposite orienta-
tion of that in TB1 could lead to a different splicing pattern
(Krummenacher, Zabolotny, and Fraser, 1997). Unlike the
TB1 virus, it was predicted that the new construct would
produce a wild-type exon and slightly larger stable intron.
To test the effect of splicing of mLAT and its exon product
on viral latency, we constructed a mutant virus FH in
which the 447 bp of lambda DNA was inserted in the
opposite direction to that in FH and TB1. The number of
HSV-1 genomes from mice latently infected with FH is
shown in Fig. 5A. Mice latently infected with FH virus
showed a similar number of latent viral genomes compared
to those infected with wild-type strain F. The genomic
structure of FH is almost identical to that of the FH
virus except for the orientation of the lambda insert. How-
ever, unlike the FH virus, FH virus utilizes the same
splice donor and acceptor as those used by wild-type (re-
sults shown below). The FH virus showed similar num-
bers of viral genomes as the wild-type, whereas FH virus
showed a reduction, indicating a role of mLAT splicing
and/or its spliced exon product in the establishment or
maintenance of latency.
Virus FH virus reactivated with delayed kinetics in the
mouse TG explant reactivation assay
To test the effect of reduction in the latent HSV-1 DNA
on viral reactivation from latency, trigeminal ganglia from
mice latently infected with F, FH, and FHR were
explanted and cocultivated with CV-1 cells as described
under Materials and Methods. The reactivation profiles of
these viruses are shown in Fig. 6A. The mutant FH
reactivated significantly slower than did the parental strain F
and the mutant FH (P  0.001 when compared to F and
FHR, Survival Analysis Log Rank Test). A slower re-
activation was also observed in the reactivation profile of
virus TB1 when compared to that of HFEM (Fig. 6B).
These data contradict a previous finding (Block et al., 1990)
and the discrepancy is discussed under Discussion.
Plasmid pH (aberrant splicing) is less protective
for cells, from apoptosis, than the wild-type plasmid
(Pst–Mlu) and plasmid pH (normal splicing)
Several reports have shown an antiapoptotic function is
associated with the HSV-1 LAT region and suggested that it
may be the mechanism by which the LAT gene promotes
latency (Ahmed et al., 2002; Inman et al., 2001; Perng et al.,
2000a). To elucidate the potential mechanism for the re-
duced viral latency of mutant virus FH, we examined the
antiapoptotic properties of LAT mutants in cells transiently
transfected with LAT plasmid constructs in a cell survival
assay (see Materials and Methods). The PstI–MluI fragment
of the wild-type and mutant LAT viruses were cloned into
expression vector pcDNA3 (Invitrogen) as previously de-
scribed, and plasmids pH and pH carry the same
mutations in the LAT region as those in mutant viruses
FH and FH. Hela cells were cotransfected with the
LAT or mutant plasmids along with a GFP-expressing plas-
mid. At 48 h posttransfection, cells were treated with an
anti-Fas antibody to induce apoptosis. Twenty-four hours
Fig. 6. Explant reactivation time course of HSV-1. Trigeminal ganglia
explanted from latently infected mouse were cocultivated with CV-1 cells
and observed for the appearance of cytopathic effects. The data represent
cumulative percentages of TG that reactivated during an 18-day period
from two independent experiments. Numbers in parentheses represent
numbers of TG scored for reactivation.
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posttreatment, GFP-positive cells that remained adherent on
the plates were counted. The data were expressed as the
percentage of GFP-positive cells that survived treatment
and the results are shown in Fig. 7. Cells transfected with
Pst–Mlu LAT and PH showed a greater protection from
anti-Fas induced apoptosis at 24 h after the treatment than
those transfected with PH and pcDNA3 (a negative
control). However, the effect is not as protective as p35, a
positive control (a baculovirus antiapoptotic protein). Sim-
ilar patterns of protection for these plasmid constructs were
also observed in SY5Y cells, a human neuronal cell line,
when apoptosis was induced by camptothecin (data not
shown).
Analysis of LAT expression
Northern blot analysis was performed to examine LAT
intron expression in productively infected cells and acutely
and latently infected mouse trigeminal ganglia.
Vero and SY5Y cells were infected with wild-type and
mutant viruses at a m.o.i of 1 and harvested 16 h postinfec-
tion. Total RNA from productively infected cells was sub-
jected to Northern blot analysis (Fig. 8A–C). In produc-
tively infected Vero cells (Fig. 8A) the 3 BstEII–BstEII
LAT intron probe (see Fig. 1) hybridized to the 2-kb LAT
intron in wild-type strain F-infected cells. This probe rec-
ognized a 0.9-kb band in FH and in TB1-infected Vero
cells. The 0.9-kb band is the intron excised using the splice
donor present in the lambda insert and the wild-type 2 kb
LAT splice acceptor site, as previously described (Krum-
menacher, Zabolotny, and Fraser, 1997). The BstEII–BstEII
probe detected a 2.2-kb band in FHinfected Vero cells.
The 2.2-kb RNA corresponds to the size expected for the
intron spliced out using the wild-type 2-kb LAT splice
donor and splice acceptor. In productively infected SY5Y
cells, levels of expression for the 2-, 0.9-, and 2.2-kb LAT
introns were similar in F-, FH-, and FH-infected cells
respectively (Fig. 8B). In contrast, in Vero cells, these
introns accumulated to different levels with the 0.9-kb in-
tron the highest (Fig. 8A). Neuro-2A cells, a mouse neuro-
nal cell line, were also infected with parental and mutant
viruses and it was found that the level of 2.2-kb intron was
about 20-fold less than that of the 2.0-kb intron (Fig. 8C). In
these cell types, the expression of viral late gene glycopro-
tein C mRNA was similar between wild-type and mutant
viruses (Fig. 8A–C).
RNA from acutely and latently infected mouse trigemi-
nal ganglia was subjected to Northern blot and results are
shown in Fig. 8D and E. The 3 LAT BstEII–BstEII probe
hybridized to the major 2-kb intron and 1.4- to 1.5-kb intron
Fig. 7. Inhibition of apoptosis by wild-type and mutant LATs expressed
from pcDNA3 vectors. HeLa cells were transfected with each of the
indicated plasmids together with equal molar amounts of pEGFP-C1. At
48 h posttransfection, anti-Fas antibody was added to HeLa cells. At 24 h
after treatment, GFP-positive cells that remained adherent on the plates
were counted. The number of GFP-positive cells in control untreated cells
represents 100% survival. The data were expressed as the percentage of
GFP-positive cells survived treatment and were average of three separate
experiments.
Fig. 8. Analysis of LAT RNA expression. RNA from productively infected
Vero cells, SY5Y cells and acutely and latently infected mouse TG were
extracted using TRIZOL reagent. (A–E) Northern blot analysis. Five mi-
crograms of RNA were separated by agarose gel electrophoresis and
vacuum-blotted to GeneScreen Plus membranes. Blots were hybridized
with a 32P-labeled BstEII–BstEII DNA probe that covered 900 bp of the 3
end of the LAT intron. (A) RNA extracted from Vero cells productively
infected with (1) wild-type strain F, (2) FH, and (3 and 4) two inde-
pendent FH clones. (B) RNA from productively infected SY5Y cells,
(1) F, (2) FH, (3) FH, and (4) FHR. (C) RNA from productively
infected Neuro-2A cells, (1) F, (2) FH, and (3) FH. Lower panels of
A–C are identical blots of the upper ones and were probed with a HSV-1
glycoprotein C probe. (D) RNA extracted from latently infected mouse
trigeminal ganglia: (1) F, (2) FH, (3) FH, and (4) FHR. (E) RNA
extracted from acutely infected mouse trigeminal ganglia at day 4 (lanes
1–3) and day 10 (lanes 4–6) postinfection: (lanes 1 and 4), F, (lanes 2 and
5) FH, and (lanes 3 and 6) FH. (F) RT–PCR analysis of LAT exon.
RNA from productively infected SY5Y cells and latently infected mouse
TG was reverse-transcribed and then subjected to PCR amplification. The
primer pair covers the 2.0-kb LAT splice junction and a PCR product of
245 bp represents the spliced wild-type LAT exon. (Lanes 1–4) RNA from
SY5Y cells infected with F (lane 1), FH (lane 2), FH (lane 3), and
mock 16 h postinfection. (Lanes 5–7) RNA from latent TG infected with
FH (lane 5), F (lane 6), and mock (lane 7).
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in wild-type HSV-1 and the rescued virus FHR-infected
trigeminal ganglia. The 0.9-kb band was detected in FH-
infected animals, but during latency the intensity of this
signal was about 14-fold less than that of the wild-type 2-kb
LAT. The weakness of the 0.9-kb band is likely a result of
less latent HSV-1 genome in the mouse trigeminal ganglia
and the smaller size of the intron. Hybridization signals in
FH-infected trigeminal ganglia were weak and can only
been seen after prolonged exposure. Bands at 2.2 and 1.1 kb
were seen in the FH-infected TG. The 2.2-kb band
corresponds to the expected intron. The 1.1-kb band may be
an alternatively spliced transcript or a splice variant from
the 2.2 intron, and the characterization of this transcript is
beyond the scope of this study.
To rule out the possibility that the low level of the 2.2-kb
intron seen in latently infected mouse TG is a result of
insufficient splicing, reverse transcription (RT) PCR analy-
sis was conducted to detect spliced LAT exon using primers
spanning the 2-kb LAT splice junction (see Materials and
Methods). The results are shown in Fig. 8F. A PCR product
of 245 bp represents the spliced wild-type LAT exon and
was detected in SY5Y cells productively infected with F
and FH viruses (Fig. 8F, lanes 1 and 3). The FH virus
produced an altered exon (a 550-bp PCR product) due to
disruption of the splicing (Fig. 8F, lanes 2). The spliced
exon was also detected in Vero cells infected with parental
and mutant viruses (data not shown). Similar levels of LAT
exon were detected in trigeminal ganglia latently infected
with F and FH viruses (Fig. 8F, lanes 5 and 6), confirm-
ing the splicing of mLAT during latency in mice infected
with FH. We were unable to detect the 550-bp exon
product in TG latently infected with FH, probably be-
cause its presence is below the level of detection.
Discussion
In the present study we have examined the effect of
replacing the 168-bp HpaI–HpaI fragment within the
HSV-1 2-kb LAT with a 447-bp lambda sequence on viral
latency. It was found that changes of latent viral genome
numbers and reactivation profiles appeared to be dependent
on the orientation of the insertion. Whereas inserting in one
direction caused a reduction of latent viral genomes
(FH) and delayed reactivation, inserting in the opposite
direction had no effect on the level of latent viral DNA
(FH). In one direction (FH) the insert introduced a
splice acceptor site and a splice donor site into the 2-kb
LAT and, as a result, a truncated stable intron and a lambda-
derived exon were produced (see Fig. 1). Inserting in the
opposite direction (FH) preserved the utilization of the
wild-type splice donor and acceptor. Thus the aberrant
splicing of LAT RNA depended on the orientation of the
lambda insert. These results suggested that splicing of the
LAT primary transcript and correctly spliced exon product
are important in regulating the establishment and/or main-
tenance of HSV-1 latency.
Expression/accumulation of LAT RNA
Earlier studies from our laboratory showed that TB1
virus produces a truncated stable 0.9-kb intron in produc-
tively infected cells (Krummenacher, Zabolotny, and
Fraser, 1997). However, this small intron was not previ-
ously detected in latently infected mouse trigeminal ganglia
(Block et al., 1990). By Northern blot analysis we showed
the presence of the 0.9-kb intron in mouse trigeminal gan-
glia infected with TB1 and FH. The level of accumula-
tion was greatly reduced during latency, whereas during
productive infection it was expressed at the wild-type level.
The low-level accumulation of the truncated intron during
latency is likely due to the fewer number of latent viral
genomes present in TB1 and FH-infected trigeminal
ganglia.
FH virus produces a 2.2-kb intron in productively
infected cells and latently infected trigeminal ganglia. This
intron, excised from the LAT primary transcript utilizing
the splice donor and acceptor of the wild-type 2-kb LAT,
contains 447 nucleotides from the lambda sequence replac-
ing 168 nucleotides of the LAT sequence. The accumulation
of this 2.2-kb intron was greatly reduced in latently infected
mouse trigeminal ganglia. We tested several independent
isolates of FH virus for intron accumulation in mouse
TG and all isolates produced very low levels of 2.2-kb
intron (data not shown), suggesting the low-level accumu-
lation was not due to a secondary mutation. It is unlikely
that the low level of the 2.2 kb intron is the result of
decreased splicing because we have confirmed the expres-
sion of exon at the wild-type level, by RT–PCR analysis, in
FH latently infected trigeminal ganglia (Fig. 8F). Pre-
liminary studies suggest there is a difference in the level of
2.2-kb intron detected in mouse neuronal cells (neuro-2A)
and human neuronal cells (SY5Y), suggesting that the low
level of the 2.2-kb intron found in mouse TG may be a result
of a defect in accumulating this intron in mouse, compared
to human, neurons (Kang and Fraser, unpublished data).
The role of the LAT gene in latency and reactivation
In the present study we showed an approximately 1 log
reduction in latent HSV-1 genome number in mouse trigem-
inal ganglia infected with FH and TB1 compared to
those infected with the parental virus strain 30 days postin-
fection. Our results provide further evidence for the function
of LAT in viral latency. Furthermore, our study suggests
that it is the splicing of the LAT primary transcript to
produce the spliced exon product that regulates latency.
Since the FH virus establishes latency similarly to the
wild-type, and there was a very low level of intron accu-
mulation in mice infected with this virus, we suggest that
the spliced LAT exon product is important in efficient
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establishment and/or maintenance of latency. The genomic
structure of FH and FH viruses are almost identical
except for the orientation of the lambda insert. As a result
the splicing pattern of the LAT gene in these two viruses
was different. The differences in latency profiles of these
two viruses suggest that maintaining a wild-type exon is
crucial for HSV-1 latency.
Although LAT has been implicated to play a role in the
establishment and maintenance of latency, the regions of the
LAT responsible for these functions remains unclear. Re-
placing large portions of the LAT gene, including the pro-
moter, exon 1, and the 2-kb intron, has been shown to cause
a reduction in the numbers of neurons containing latent
HSV-1 genomes in both rabbit and mouse models (Perng et
al., 2000b; Sawtell and Thompson, 1992). A small deletion
in the LAT promoter region has also been shown to cause a
decrease in the numbers of latently infected neurons, indi-
cating that transcription of the LAT primary transcript is
necessary for efficient establishment or maintenance of viral
latency (Thompson and Sawtell, 1997). In our study the
LAT primary transcripts produced by FH and FH
viruses are identical except for the orientation of the lambda
insert. Nevertheless, the FH virus showed a reduction in
latent HSV-1 DNA, suggesting that the splicing of the
primary transcript is important in the latency process. Stud-
ies by Arthur et al. suggested a reduced level of viral latency
in mice infected with a virus carrying mutations in the 2-kb
LAT splice donor site, though the reduction was not con-
sistently demonstrated in that study (Arthur et al., 1998).
That mutant virus was still capable of expressing low level
of intron in latently infected neurons, possibly excised from
a cryptic splice site. Nevertheless, their study supports the
hypothesis that splicing of the LAT primary transcript is
important for the establishment and maintenance of viral
latency. Our data also argue against the hypothesis that a
DNA sequence in the LAT region is responsible for efficient
establishment of latency because FH and FH viruses
have identical sequences in this region.
Although latency establishment/maintenance and reacti-
vation are thought to be two independent processes, a cor-
relation between the frequency of reactivation and the num-
bers of latently infected neurons has been suggested
(Sawtell, 1998). Increased numbers of latently infected neu-
rons may provide a larger pool from which virus can reac-
tivate. Results from our study support this hypothesis. It is
possible that the delayed reactivation of FH and TB1 is
a result of a reduction in level of viral DNA during latency.
The reactivation profiles of FH and TB1 contradict an
earlier report in which TB1 was judged to reactivate with
similar kinetics to the parental strain (Block et al., 1990).
The discrepancy may result from the different doses of
HSV-1 used to infected mice (a higher dose was used in the
previous study). Recent work from Perng et al. suggests that
the effect of HSV-1 LAT on TG explant reactivation in
BALB/c mice may be dose-dependent (Perng et al., 2001).
Mechanisms by which LAT promotes latency
There is general agreement in the field that LAT is
capable of enhancing neuronal survival, but the mechanism
by which LAT promotes latency is still in debate. Several
potential mechanisms have been proposed. It has been sug-
gested that LAT down-regulates the expression of viral lytic
cycle genes and therefore helps infected neurons escape
clearance by the host immune system (Garber et al., 1994).
Recently studies have shown an antiapoptotic function is
associated with the LAT region, and this may be the mech-
anism by which the LAT gene promotes neuron survival
and enhances latency. We have previously shown that la-
tency is established as soon as the viral DNA reaches the
neuronal cell nucleus (Steiner et al., 1990). Although there
is evidence that the LAT may play a role in establishment of
latency (Thompson and Sawtell, 2001), our study suggests
that it is during maintenance of latency that the antiapop-
totic function of the LAT gene may be active in preserving
the latently infected cells. Using transiently transfected
cells, we showed that plasmid pH is less effective than
the wild-type and pH at protecting against cell death
(Fig. 7), indicating that reduced latency in FH and TB1-
infected mouse TG may be a result of a decreased protection
against apoptosis. We examined apoptosis in mouse TG at
days 5–6 postinfection (acute infection), a time during
which we observed a rapid decline in viral DNA. There
were only a small number of apoptotic cells found in the TG
and they appeared to be small satellite cells. There was no
difference in the staining pattern between the mutant and the
parental strain (data not shown). This is consistent with
previous reports by Thompson and Sawtell (2001) and
Ahmed et al. (2002). Our data showed that at day 10
postinfection, FH and TB1 had similar levels of DNA as
their parental strains (Fig. 4). At this time we never detect
infectious virus in TG. Therefore, the reduced viral DNA in
FH- and TB1-infected TG during latency (day 30 postin-
fection) is probably the result of losing viral DNA over a
period of time (between day 10 and day 30), and it is
possible that LAT enhances latency by preventing cell death
during this long time period. The direct detection and quan-
titation of LAT antiapoptotic activity over this time scale in
latently infected TG will be a tour de force and is beyond
the scope of this study.
Studies by Inman et al. have shown that the antiapoptotic
activity of the LAT locus resides entirely within the first 1.5
kb of LAT primary transcript, and the first 811 bp of LAT
primary transcript has only partial antiapoptotic activity
(Inman et al., 2001). The mutations in our study lie imme-
diate downstream of the 1.5-kb LAT. The aberrant splicing
in FH results in a transcript containing lambda se-
quences that may alter the structure or the subcellular dis-
tribution of the transcript and thus may not be active al-
though it contains the partial sequences mapped as
antiapoptotic by Wechsler’s group in the experiments with
their constructs.
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Our present work suggests that the splicing of LAT
primary transcript, and the resulting exon product, are im-
portant in the latency process. Splicing of pre-mRNA has
been shown to affect downstream mRNA metabolism by
specifically altering the protein composition of the product
messenger ribonucleoprotein particle (mRNP) in the vicin-
ity of exon–exon junctions (Le Hir, Moore, and Maquat,
2000). Exon–exon junction complexes (EJCs) in mRNA
have been shown to play an important role in enhancing
mRNA translation and export (Lou and Reed, 1999; Matsu-
moto, Wassarman, and Wolffe, 1998). EJCs are also in-
volved in nonsense-mediated mRNA decay, allowing dis-
tinction between premature and normal termination codons
(Cheng et al., 1994). Factors that bind to the EJC of HSV-1
LAT, and the effect of this binding on mRNA translation
and metabolism, remain to be determined. They may play a
role in the mechanism of LAT gene function.
Although the LAT gene has been implicated to play a
role in latency and reactivation, it is still unclear whether
LAT gene function is mediated by a protein or an RNA and
whether the exon, intron, or both play a role. Studies map-
ping the region of the LAT gene responsible for spontane-
ous reactivation suggest that the first 1.5 kb of the LAT
primary transcript is important for cell survival and spon-
taneous reactivation (Inman et al., 2001). A recent study
from Sawtell and Thompson showed a similar region of the
LAT primary transcript promotes neuronal survival and
efficient establishment of latency (Thompson and Sawtell,
2001). Studies examining the open reading frames in the
first 1.5 kb of mLAT suggest that protein products from this
region are unlikely (Drolet et al., 1998; Lagunoff and Roiz-
man, 1994). However, work by Lock et al. showed the
possibility of a nuclear localization signal may exist in the
LAT exon 1 region (Lock, Miller, and Fraser, 2001). Sup-
porting the hypothesis that the LAT exons encode a trans-
latable ORF during viral infection, Zhu et al. demonstrated
that transgenes inserted into the exon 1 region of LAT can
be translated during both productive and latent infections in
mouse brain (Zhu et al., 2000). The LAT may act as a
regulatory RNA. A 348-bp region of 5 LAT has been
shown to process homology to the XIST transcript on the X
chromosome. It may play a role in silencing the HSV-1
genome, a mechanism similar to that of the XIST transcript
(Bloom et al., 1999). Recently we have shown the 2-kb LAT
intron associates with ribosomal proteins and splicing fac-
tors, suggesting that the LAT intron may mediate its func-
tion through a structural role in its interaction with the
cellular translation machinery (Ahmed and Fraser, 2001).
Conclusion
Through the use of plasmid constructs, engineered to
affect LAT splicing, and the equivalent viral mutants, we
have demonstrated that although there is no significant dif-
ference in DNA levels during early (acute) times of infec-
tion, there is a statistically different level of DNA at a late
(latent) time. The constructs which lead to maintenance of
low levels of viral DNA have low levels of stable LAT
intron in latently infected neurons and reactivate less effi-
ciently than the parental strains.
Materials and methods
Cells and viruses
African green monkey kidney cells (Vero) were grown in
Dulbecco’s modified Eagle’s medium supplement with 5%
calf serum at 37°C with 5% CO2. SY5Y cells, a neuroblas-
toma cell line, were maintained in RPMI-1640 medium
(Gibco/BRL, Carlsbad, CA) with 10% fetal calf serum. All
HSV-1 viruses were propagated on Vero cells. Virus titers
were determined on Vero cells. TB1, a LAT mutant virus,
was derived from HSV-1 strain HFEM as previously de-
scribed (Block et al., 1990). In this virus, the 168-bp Hpa–
Hpa fragment (nt 120302 to nt 120470) within the 2-kb
LAT was replaced by a 447-bp bacteriophage lambda DNA.
Construction of mutant virus FH and FH
The LAT mutant viruses, FH and FH, were gen-
erated from parental HSV-1 strain F by homologous recom-
bination. Plasmids pH and pH (Krummenacher,
Zabolotny, and Fraser, 1997) were used to construct virus
FH and FH respectively. FHR, a FH rescuant,
was constructed by cotransfecting FH viral DNA with
plasmid pcDNAPst–Mlu (Krummenacher, Zabolotny, and
Fraser, 1997). Plasmid DNA was linearized with restriction
enzyme EcoRI and HindIII (New England Biolabs) and then
cotransfected with HSV-1 viral DNA using lipofectamine
(Gibco/BRL). Recombinant viruses were selected through
four rounds of plaque purification (Johnson and Friedmann,
1994). The 447-bp lambda DNA fragment was labeled with
fluorescein using a random-priming labeling kit (NEN Life
Science, Boston, MA) to make the probe for plaque screen-
ing. Mutant virus constructs were verified by Southern
blots. Briefly, viral DNA was prepared from infected Vero
cells. They were then digested with restriction enzymes,
separated by agarose gel electrophoresis, and transferred to
nitrocellulose membranes (Protran BA85, Schleicher &
Schuell, Keene, NH). DNA probes were labeled with fluo-
rescein and hybridization was performed according to the
manufacturer’s instruction (NEN Life Science). Orientation
of the lambda insert was confirmed by restriction enzyme
digestions following PCR amplification of HSV-1 LAT
region. Primer PF and PR2 were used to amplify the first
1030 bp of the 2-kb LAT intron (see Fig. 1 for positions).
The PCR amplification was performed using a Dynazyme
EXT DNA polymerase kit (MJ research, Watertown, MA).
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The PCR condition and primer sequences have been de-
scribed previously (Spivack, Woods, and Fraser, 1991).
Infection of mice and extraction of DNA from mouse
trigeminal ganglia
This study was approved by the Institutional Animal
Care and Use Committee of the Wistar Institute and the
Principles for Care and Use of Laboratory Animals of NIH
were followed. Female BALB/C BYJ mice (Taconic, NY),
4–6 weeks of age, were infected with parental or mutant
HSV-1 by bilateral corneal scarification at approximately
106 PFU per eye. At various time points postinfection, mice
were sacrificed. Three pairs of trigeminal ganglia (six total)
were pooled as one group and were frozen immediately.
Trigeminal ganglionic DNA was extracted as previously
described (Treco, 1990) with slight modification. Briefly,
ganglia were digested at 37°C overnight in a lysis buffer
containing 0.25 mg/ml proteinase K, 10 mM Tris (pH 8),
0.01 mM EDTA, and 0.6% sodium dodecyl sulfate (SDS).
DNA was isolated by two rounds of standard phenol–chlo-
roform extraction and precipitated with isopropyl alcohol.
Explant reactivation from latently infected mouse
trigeminal ganglia
At a minimum of 30 days postinoculation, mice were
sacrificed and their trigeminal ganglia were removed and
incubated with monolayers of CV-1 cells. The cells were
inspected daily for signs of cytopathic effects. Ganglia were
transferred every 4–5 days to new cells until reactivation
occurred or for 18 days.
Quantitative PCR analysis
HSV-1 genome copy numbers present in infected mouse
TG were determined by quantitative PCR analysis measur-
ing viral gene UL54 and ribonucleotide reductase (RR). The
cellular gene cyclophilin was also amplified to use as a
control. Primer sequences have been described elsewhere
(Tal-Singer et al., 1997). A PCR standard curve was made
by serial diluting HSV-1 virion DNA in 100 ng/l mouse
genomic DNA to final ratios of 1000, 100, 10, 1, 0.1, 0.01,
and 0.001 HSV-1 genome copies per cell. DNA extracted
from infected TG was also diluted to a final concentration of
100 ng/l. PCR amplification was carried out as follows:
Five microliters of DNA diluent were added to a final 100
l of reaction mix containing 20 mM Tris (pH 8.4), 50 mM
KCl, 0.2 mM of each dNTP, 1.5 mM MgCl2, 0.5 M of
each primer, 2% DMSO, and 2.5 units of Taq polymerase
(Gibco/BRL). Amplification consisted of 35 cycles of de-
naturation at 94°C for 1 min, annealing at 54°C for 30 s, and
extension at 72°C for 1 min using a Perkin–Elmer thermal
cycler (Model No. 2400). PCR products were resolved by
agarose gel electrophoresis and visualized by ethidium bro-
mide staining. The yields of PCR products were measured
by densitometric analysis using an Alpha imager (Alpha
Innotech, San Leandro, CA).
RNA extraction and Northern blot analysis
Vero cells and SY5Y cells were infected with HSV-1 at
a m.o.i. of 1 and harvested 16 h postinfection. Total RNA
from productively infected cells or infected mouse TG was
extracted using TRIZOL reagent according to manufactur-
er’s instruction (Gibco/BRL). Northern blot analysis was
performed as described (Spivack and Fraser, 1988). Briefly,
5 g of total RNA was denatured with glyoxal, electropho-
resed in 1.2% agarose gels, and vacuum blotted to Gene-
Screen Plus membrane (NEN, Boston, MA). RNA makers
were purchased from Ambion (Austin, TX). The blots were
prehybridized for 2 h at 50°C in a buffer containing 50%
formamide, 10% dextran sulfate, 1X Denhardt’s solution,
1% SDS, 5X SSC, 1 mM EDTA, and 1% denatured salmon
sperm DNA. DNA probes were labeled with -[32P]dCTP
using a random priming labeling kit (Gibco/BRL). Heat
denatured probes were added to the prehybridization mix
and incubated overnight. The blots were washed in buffers
with decreasing concentrations of SSPE (1, 0.5, and 0.1X)
and 1% SDS at 65°C, twice for 20 min per wash, and
exposed to PhosphorImager screen (Molecular Dynamics,
Sunnyvale, CA).
RT–PCR analysis of spliced LAT exon
The detection of spliced LAT exon product by RT–PCR
has been described in details previously (Krummenacher,
Zabolotny, and Fraser, 1997). Briefly, the cDNA was syn-
thesized from DNAase treated RNA using the Superscript II
first strand synthesis system (Invitrogen), and the instruc-
tion for high GC content RNA was followed. PCR ampli-
fication was performed using the Dynazyme EXT polymer-
ase kit (MJ Research, Watertown, MA) and a primer pair
(Exon1 and Exon2N) that spans the 2.0-kb LAT splice
junction (Krummenacher, Zabolotny, and Fraser, 1997).
Transfections and induction of apoptosis
Cells were transfected with a plasmid expressing wild-
type or mutant LAT together with the plasmid pEGFP-C1
(Clontech) as previously described (Ahmed et al., 2002).
Two days after transfection, HeLa cells were treated with 1
g/ml of anti-Fas monoclonal antibody CH-11 (Tanvera,
Madison, WI) and SY5Y cells were incubated with 4 g/ml
of Camptothecin (Sigma, St. Louis, MO). Twenty-four
hours after anti-Fas and 16 h after Camtothecin treatments,
cells adherent on plates were collected and the number of
GFP-positive cells were counted under a fluorescent micro-
scope. The number of GFP-positive cells in untreated cells
were counted to serve as the 100% survival.
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